Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €25.85 EUR
Change Today -0.75 / -2.84%
Volume 508.8K
OCI On Other Exchanges
Symbol
Exchange
EN Amsterdam
OTC US
Stuttgart
Berlin
OTC US
As of 11:35 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

oci nv (OCI) Snapshot

Open
€26.65
Previous Close
€26.61
Day High
€26.79
Day Low
€25.85
52 Week High
02/26/15 - €33.53
52 Week Low
10/8/14 - €18.61
Market Cap
5.4B
Average Volume 10 Days
341.8K
EPS TTM
€2.08
Shares Outstanding
210.1M
EX-Date
--
P/E TM
13.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for OCI NV (OCI)

Related News

No related news articles were found.

oci nv (OCI) Related Businessweek News

No Related Businessweek News Found

oci nv (OCI) Details

OCI N.V. produces and distributes nitrogen fertilizers and natural gas-based industrial chemicals to agricultural and industrial customers worldwide. The company offers anhydrous ammonia in liquid and gaseous form, granular urea, urea ammonium nitrate solution, calcium ammonium nitrate, methanol, and melamine, as well as distributes crystalline and granular ammonium sulphate. It is also involved in the trading and distribution of fertilizers, as well as owns and operates ammonia terminal. The company sells its products in approximately 20 countries across Europe, the Americas, Asia, and Africa. OCI N.V. is headquartered in Amsterdam, the Netherlands.

33,282 Employees
Last Reported Date: 04/29/15

oci nv (OCI) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: $3.0M
Chief Financial Officer and Executive Directo...
Total Annual Compensation: $2.5M
Compensation as of Fiscal Year 2014.

oci nv (OCI) Key Developments

OCI N.V. Reports Earnings Results for the Full Year 2014; Provides Capital Expenditures Guidance for the Full Year 2015

OCI N.V. reported earnings results for the full year 2014. For the period, the company’s revenues increased by 8% from $2.5 billion in 2013 to $2.7 billion in 2014. Revenues increased primarily due to higher product volumes sold. Product prices were relatively stable. The EBITDA excluding one-off items increased by 23% to $833 million. Net income from continuing operations for the year was $444 million, a 42% increase compared to 2013. Net debt, as expected, increased by $650 million compared with the restated figures for December 31 and was just under $4.2 billion. The increase was a result of capital expenditure for Iowa Fertilizer Company and debottlenecking project at company Beaumont. Total capital expenditure was $1.2 billion in 2014, an increase from $687 million in 2013. This year 2015, the company will still have high capital expenditure at about a similar level as in 2014 related to the 3 development projects in the U.S., namely, the debottlenecking at OCI Beaumont, which is now complete and finalized and the facility is back up and running.

OCI N.V. to Report Fiscal Year 2014 Results on Apr 29, 2015

OCI N.V. announced that they will report fiscal year 2014 results on Apr 29, 2015

OCI N.V. Announces Board Changes

OCI N.V. announced that its Non-Executive Board of Directors will propose the appointment of Mr. Gregory Heckman as an independent non-executive member of the Board of Directors to the next general meeting of shareholders to be held on 10 June 2015. Mr. Heckman is a US citizen with more than 30 years of experience in the agriculture and energy industries. From 2008 until 2014, he was president and chief executive officer of The Gavilon Group, LLC. Further, at the AGM on 10 June 2015, Mr. Kees van der Graaf will not continue his term as an independent non-executive member of the Board of Directors of the company in order to dedicate more time to his bio-tech start-up Facio Therapies BV. Mr. Van der Graaf has served the company's Board of Directors since 2013, chaired the Health, Safety and Environment Committee and has also been a member of the Nomination & Governance Committee during that time.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCI:NA €25.85 EUR -0.75

OCI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Agrium Inc C$126.36 CAD -0.51
CF Industries Holdings Inc $293.80 USD -0.70
Koninklijke DSM NV €52.05 EUR +1.10
Potash Corp of Saskatchewan Inc C$39.41 CAD -0.11
Yara International ASA 394.60 NOK +8.20
View Industry Companies
 

Industry Analysis

OCI

Industry Average

Valuation OCI Industry Range
Price/Earnings 14.4x
Price/Sales -- Not Meaningful
Price/Book 2.9x
Price/Cash Flow 19.1x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCI NV, please visit www.ocinv.nl. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.